SE0004780D0 - Novel compunds - Google Patents

Novel compunds

Info

Publication number
SE0004780D0
SE0004780D0 SE0004780A SE0004780A SE0004780D0 SE 0004780 D0 SE0004780 D0 SE 0004780D0 SE 0004780 A SE0004780 A SE 0004780A SE 0004780 A SE0004780 A SE 0004780A SE 0004780 D0 SE0004780 D0 SE 0004780D0
Authority
SE
Sweden
Prior art keywords
medicament
compounds
compunds
novel
novel compunds
Prior art date
Application number
SE0004780A
Other languages
English (en)
Inventor
Adnan Badwan
Original Assignee
Jordanian Pharmaceutical Mfg &
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jordanian Pharmaceutical Mfg & filed Critical Jordanian Pharmaceutical Mfg &
Priority to SE0004780A priority Critical patent/SE0004780D0/sv
Publication of SE0004780D0 publication Critical patent/SE0004780D0/sv
Priority to US10/015,591 priority patent/US20020151552A1/en
Priority to JP2001385409A priority patent/JP3940290B2/ja
Priority to EP01850213A priority patent/EP1219614A1/en
Priority to US10/848,536 priority patent/US7084144B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96—Sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/04—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/28—Nitrogen atoms
    • C07D295/30—Nitrogen atoms non-acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
SE0004780A 2000-12-22 2000-12-22 Novel compunds SE0004780D0 (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE0004780A SE0004780D0 (sv) 2000-12-22 2000-12-22 Novel compunds
US10/015,591 US20020151552A1 (en) 2000-12-22 2001-12-17 Novel compounds
JP2001385409A JP3940290B2 (ja) 2000-12-22 2001-12-19 新規化合物
EP01850213A EP1219614A1 (en) 2000-12-22 2001-12-20 Benzene sulfonamides as PDE-V inhibitors for the use against erectile dysfunction
US10/848,536 US7084144B2 (en) 2000-12-22 2004-05-19 Sulfonyl group containing compounds and their use for the treatment of erectile dysfunction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0004780A SE0004780D0 (sv) 2000-12-22 2000-12-22 Novel compunds

Publications (1)

Publication Number Publication Date
SE0004780D0 true SE0004780D0 (sv) 2000-12-22

Family

ID=20282360

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0004780A SE0004780D0 (sv) 2000-12-22 2000-12-22 Novel compunds

Country Status (2)

Country Link
US (2) US20020151552A1 (sv)
SE (1) SE0004780D0 (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT504704B1 (de) * 2006-06-14 2008-12-15 Chemiefaser Lenzing Ag Fasern enthaltender gegenstand
WO2011102436A1 (ja) * 2010-02-17 2011-08-25 国立大学法人京都大学 ＴＧＦ－βシグナル伝達阻害剤

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2507408A (en) * 1948-03-05 1950-05-09 Rhone Poulenc Sa 1-alkylsulfonyl-4-alkyl piperazines
DE3065026D1 (en) 1979-05-23 1983-11-03 Beecham Wuelfing Gmbh & Co Kg Phenylsulphonamide derivatives, a process for their preparation and their use as medicines
DE3008225A1 (de) * 1980-03-04 1981-09-17 Hoechst Ag, 6000 Frankfurt Verfahren und herstellung von 2-merkaptobenzthiazolen
CA1305148C (en) 1987-08-19 1992-07-14 Hiromu Matsumura Carbamoylpyrrolidone derivatives and drugs for senile dementia
JP2556722B2 (ja) 1988-02-18 1996-11-20 興和株式会社 新規なスルホンアミド化合物
GB9013750D0 (en) 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
KR0134069B1 (ko) 1993-02-19 1998-04-22 유미꾸라 레이이찌 벤조티아졸 술폰아미드 유도체, 그의 제조법 및 그의 용도
GB9301192D0 (en) 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
IT1266582B1 (it) 1993-07-30 1997-01-09 Recordati Chem Pharm Derivati (di)azacicloesanici e diazacicloeptanici
EP0661266A1 (en) 1993-12-27 1995-07-05 Toa Eiyo Ltd. Substituted cyclic amine compounds as 5HT2 antagonists
AU5320698A (en) * 1996-11-20 1998-06-10 Byk Gulden Lomberg Chemische Fabrik Gmbh Substituted dihydrobenzofurans as pde inhibitors
TR199902646T2 (xx) 1997-04-25 2000-05-22 Pfizer Inc. Seks�el bozuklu�un tedavisi i�in pirazolopirimidinonlar.
AU7453498A (en) 1997-05-30 1998-12-30 Takeda Chemical Industries Ltd. Sulfonamide derivatives, their production and use
AR016384A1 (es) 1997-07-30 2001-07-04 Smithkline Beecham Corp Inhibidores de caspasas, composiciones farmaceuticas que comprenden dichos inhibidores de caspasas y uso de los inhibidores de caspasas para prepararun medicamento util para el tratamiento de apoptosis y desordenes asociados con excesiva actividad de la convertosa il-1 beta.
NZ502965A (en) 1997-11-25 2002-03-01 Warner Lambert Co Benzenesulfonamide inhibitors of phosphodiesterase-IV for treating inflammation and TNF associated diseases
DE19825182A1 (de) 1998-06-05 1999-12-09 Agfa Gevaert Ag Reifung von Silberhalogenidemulsionen
ATE228134T1 (de) 1999-06-04 2002-12-15 Jordanian Pharmaceutical Mfg A Kondensierte pyrimidinderivate und diese enthaltende pharmazeutische zubereitungen

Also Published As

Publication number Publication date
US20050080088A1 (en) 2005-04-14
US20020151552A1 (en) 2002-10-17
US7084144B2 (en) 2006-08-01

Similar Documents

Publication Publication Date Title
MY143795A (en) Tetrahydropyridoindole derivatives
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
ATE286500T1 (de) 1,2,3,4-tetrahydroisochinolin-derivate
DK1157037T3 (da) GCSF-konjugater
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
MXPA02012425A (es) Compuestos nuevos.
ATE452129T1 (de) N-phenyl-2-pyrimidine-amine derivatives
DE60133555D1 (de) Verbindungen und gemische zur verabreichung eines aktiven agens
SE0001899D0 (sv) New compounds
DE60038183D1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
CO5631443A2 (es) Derivados de 7-aril-3,9-diazabiciclo (3.3.1) non-6-eno y su uso como inhibidores de renina en el tratamiento de enfermedades de hipertension, cardiovasculares o renales
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
ATE486587T1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
TW200514772A (en) Novel tetrahydropyridine derivatives
SE0302139D0 (sv) Novel compounds
MY135850A (en) Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
SE9902765D0 (sv) Novel compounds
ATE383345T1 (de) Quinoxalin-3-on-verdindungen als orexin-rezeptor antagonisten.
MXPA04001252A (es) Nuevos heterociclos benzo-fusionados como antagonistas de endotelina.
SE0003476D0 (sv) Compounds
MXPA03000606A (es) Derivados de benzofurano y su uso como agentes antibacterianos.
MXPA05008400A (es) Derivados de oxazolidinona n-sustituidos por un anillo triciclico, para su uso como agentes antibacterianos.
SE0004780D0 (sv) Novel compunds
SE0000303D0 (sv) Novel compounds
GB0012795D0 (en) Organic compounds